Selective Serotonin Reuptake Inhibitors
作者： Frans de Jonghe , Jan Swinkels
DOI: 10.2165/00023210-199707060-00004
关键词: Citalopram 、 Fluoxetine 、 Psychopharmacology 、 Paroxetine 、 Fluvoxamine 、 Pharmacology 、 Tolerability 、 Medicine 、 Sertraline 、 Reuptake inhibitor 、 Pharmacology (medical) 、 Psychiatry and Mental health 、 Clinical neurology
摘要: In this article, we raise the following question regarding treatment of depression with selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors (SSRIs) citalopram, fluoxetine, fluvoxamine, paroxetine and sertraline: are there clinically relevant differences between these SSRIs in terms their (i) pharmacodynamic pharmacokinetic (ii) clinical (i.e. efficacy, tolerability, adverse events safety) profiles?
springer.com
sci-hub.se 参考文章(41)
Brown Wa, Harrison W, Are patients who are intolerant to one SSRI intolerant to another Psychopharmacology Bulletin. ,vol. 28, pp. 253- 256 ,(1992)
Sheldon H. Preskorn, Pharmacokinetics of antidepressants: Why and how they are relevant to treatment. The Journal of Clinical Psychiatry. ,vol. 54, pp. 14- 20 ,(1993)
Cara Riesenman, Antidepressant Drug Interactions and the Cytochrome P450 System: A Critical Appraisal Pharmacotherapy. ,vol. 15, ,(1995) , 10.1002/J.1875-9114.1995.TB02909.X
W.A. Arrindell, J.H.M. Ettema, SCL-90. Handleiding bij een multidimensionele psychopathologie-indicator Swets & Zeitlinger. ,(2003)
Jacqueline J. Martindale, Ernest H. Bennie, John M. Mullin, A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression The Journal of Clinical Psychiatry. ,vol. 56, pp. 229- 237 ,(1995)
Roger Lane, David Baldwin, Sheldon Preskorn, The SSRIs: advantages, disadvantages and differences Journal of Psychopharmacology. ,vol. 9, pp. 163- 178 ,(1995) , 10.1177/0269881195009002011
Aaron T. Beck, Alice Beamesderfer, Assessment of depression: the depression inventory. Modern problems of pharmacopsychiatry. ,vol. 7, pp. 151- 169 ,(1974) , 10.1159/000395074
JEAN TIGNOL, A double-blind, randomized, fluoxetine-controlled multicenter study of paroxetine in the treatment of depression Journal of Clinical Psychopharmacology. ,vol. 13, ,(1993) , 10.1097/00004714-199312002-00003
W. Schöne, M. Ludwig, Paroxetin in der Depressionsbehandlung geriatrischer Patienten: eine doppelblinde Vergleichsstudie mit Fluoxetin Fortschritte Der Neurologie Psychiatrie. ,vol. 62, pp. 16- 18 ,(1994) , 10.1055/S-2007-1002356
C. Geretsegger, F. Böhmer, M. Ludwig, Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects International Clinical Psychopharmacology. ,vol. 9, pp. 25- 29 ,(1994) , 10.1097/00004850-199400910-00004